Focus on intrauterine contraception in 15 questions-answers;Mise au point sur la contraception intra-utérine en 15 questions-réponses

Gynecologie Obstetrique et Fertilite

Volumn 40, Issue 1, 2012, Pages 37-42

  Gronier, H ^a   Letombe, B ^a   Collier, F ^a   Dewailly, D ^a   Robin, G ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Contraceptive methods; Copper intrauterine device; Levonorgestrel intrauterine system

Indexed keywords

CLINICAL PRACTICE; CONTRACEPTION; GYNECOLOGY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; QUESTIONNAIRE; REVIEW;

EID: 84855419853     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2011.07.022     Document Type: Article

References (60)

1. OMS. Mechanism of action safety and efficacy of intrauterine devices 1987 WHO Geneva
2. S.J. Segal, F. Alvarez-Sanchez, C.A. Adejuwon, V. Brache de Mejia, P. Leon, and A. Faundes Absence of chorionic gonadotropin in sera of women who use intrauterine devices Fertil Steril 44 1985 214 218 (Pubitemid 15015175)
3. Boudineau M, Multon O, Lopes P. Contraception par dispositifs intra-utérins. Encycl Med. Paris : Elsevier. Gynécologie 2001; 738-A-09:1-7.
4. R.S. French, F.M. Cowan, D. Mansour, J.P. Higgins, A. Robinson, and T. Procter Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives BJOG 107 2000 1218 1225
5. H.O. Critchley, H. Wang, R.L. Jones, R.W. Kelly, T.A. Drudy, and A.E. Gebbie Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery Hum Reprod 13 1998 1218 1224 (Pubitemid 28279173)
6. H. Luo, P. Zhu, R. Xu, J. Cheng, X. Zhao, and J.D. Wang Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device Anal Quant Cytol Histol 21 1999 409 412
7. E. Mandelin, H. Koistinen, R. Koistinen, B. Affandi, and M. Seppala Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism? Hum Reprod 12 1997 2671 2675 (Pubitemid 28031728)
8. I. Jarvela, T. Raudaskoski, A. Tekay, and P. Jouppila Effect of the levonorgestrel-releasing intrauterine system on the uterine artery pulsatility index in postmenopausal hormone replacement therapy Ultrasound Obstet Gynecol 10 1997 350 355 (Pubitemid 28026314)
9. I. Jarvela, A. Tekay, and P. Jouppila The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women Hum Reprod 13 1998 3379 3383 (Pubitemid 29002626)
10. T. Luukkainen, and J. Toivonen Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties Contraception 52 1995 269 276
11. ANAES, AFSSAPS,2004 Stratégies de choix des méthodes contraceptives chez la femme.
12. D.J. Mosure, S. Berman, D. Kleinbaum, and Halloran ME Predictors of chlamydia trachomatis infection among female adolescents: a longitudinal analysis Contraception 144 1996 997 1003 (Pubitemid 26383181)
13. J. Trussell Contraceptive failures in the united states Contraception 70 2004 89 96
14. C. Moreau, J. Trussell, G. Rodriguez, N. Bajos, and J. Bouyer Contraceptive failure rates in France: results from a population-based survey Hum Reprod 22 9 2007 2422 2427 (Pubitemid 47289056)
15. I. Sivin, J. Stern, E. Coutinho, C.E. Mattos, S. el Mahgoub, and S. Diaz Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the copper T380 Ag IUDS Contraception 44 1991 473 480
16. P. Thonneau, T. Almont, E. de La Rochebrochard, and B. Maria Risk factors for IUD failure: results of a large multicentre case-control study Hum Reprod 21 2006 2612 2616 (Pubitemid 44542153)
17. D.A. Grimes, D. Hubacher, L.M. Lopez, and K.F. Schulz Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use Cochrane Database Syst Rev 2006 CD006034
18. P. Pakarinen, J. Toivonen, and T. Luukkainen Therapeutic use of the LNG IUS, and counseling Semin Reprod Med 19 2001 365 372 (Pubitemid 34028424)
19. J.W. Barrington, and P. Bowen-Simpkins The levonorgestrel intrauterine system in the management of menorrhagia Br J Obstet Gynaecol 104 1997 614 616 (Pubitemid 27240431)
20. L. Bahamondes, C.A. Petta, A. Fernandes, and I. Monteiro Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea Contraception 75 2007 S134 S139 (Pubitemid 46770697)
21. A.M. Bragheto, N. Caserta, L. Bahamondes, and C.A. Petta Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging Contraception 76 2007 195 199 (Pubitemid 47247668)
22. K. Jindabanjerd, and S. Taneepanichskul The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women J Med Assoc Thai 89 Suppl 4 2006 S147 S151
23. R.A. Kadir, and C. Chi Women and von Willebrand disease: controversies in diagnosis and management Semin Thromb Hemost 32 2006 605 615 (Pubitemid 44453021)
24. G. Robin, P. Massart, and B. Letombe Contraception in French teenage girls in 2007 Gynecol Obstet Fertil 35 2007 951 967 (Pubitemid 47576691)
25. S. Suhonen, M. Haukkamaa, T. Jakobsson, and I. Rauramo Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69 2004 407 412 (Pubitemid 38510332)
26. G. Robin, and D. Dewailly La périménopause en 2007 : de la physiopathologie la prise en charge thérapeutique Med Ther Med Reprod 9 2007 114 123 (éditeur J. Libbey) (Pubitemid 46781464)
27. R. Sitruk-Ware The levonorgestrel intrauterine system for use in peri- and postmenopausal women Contraception 75 2007 S155 S160 (Pubitemid 46770707)
28. B.L. Xiao, L.Y. Zhou, X.L. Zhang, M.C. Jia, T. Luukkainen, and H. Allonen Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device Contraception 41 1990 353 362 (Pubitemid 20134344)
29. G. Boutet Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice? Gynecol Obstet Fertil 34 2006 1015 1023 (Pubitemid 44829975)
30. X.B. Trinh, W.A. Tjalma, A.P. Makar, G. Buytaert, J. Weyler, and P.A. van Dam Use of the levonorgestrel-releasing intrauterine system in breast cancer patients Fertil Steril 90 2008 17 22 (Pubitemid 351885178)
31. T. Backman, I. Rauramo, K. Jaakkola, P. Inki, K. Vaahtera, and A. Launonen Use of the levonorgestrel-releasing intrauterine system and breast cancer Obstet Gynecol 106 2005 813 817 (Pubitemid 41362188)
32. J. Dinger, K. Bardenheuer, and T.D. Minh Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer Contraception 83 2011 211 217
33. L. Zhou, and Xiao B Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial Contraception 64 2001 107 112
34. G. Robin, and B. Letombe Non-hormonal contraception Rev Prat 58 2008 29 40
35. P.F. Thonneau, and T.E. Almont Contraceptive efficacy of intrauterine devices Am J Obstet Gynecol 198 2008 248 253
36. D. Hubacher, V. Reyes, S. Lillo, A. Zepeda, P.L. Chen, and H. Croxatto Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen Am J Obstet Gynecol 195 2006 1272 1277 (Pubitemid 44635393)
37. I. Saav, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-Danielsson Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial Hum Reprod 22 2007 2647 2652 (Pubitemid 47434207)
38. T. Walsh, D. Grimes, R. Frezieres, A. Nelson, L. Bernstein, and A. Coulson Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices Lancet 351 1998 1005 1008 (Pubitemid 28154375)
39. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72 (Pubitemid 24077388)
40. I.F. Gareen, S. Greenland, and H. Morgenstern Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990 Epidemiology 11 2000 589 597 (Pubitemid 30660039)
41. T.M. Farley, M.J. Rosenberg, P.J. Rowe, J.H. Chen, and O. Meirik Intrauterine devices and pelvic inflammatory disease: an international perspective Lancet 339 1992 785 788
42. V. Kalaichelvan, A.A. Maw, and K. Singh Actinomyces in cervical smears of women using the intrauterine device in Singapore Contraception 73 2006 352 355 (Pubitemid 43375093)
43. G.S. Merki-Feld, E. Lebeda, B. Hogg, and P.J. Keller The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices Contraception 61 2000 365 368 (Pubitemid 30665811)
44. D. Serfaty Contraception 2007 Abrégés Masson [315]
45. D. Serfaty Conduite tenir chez les utilisatrices de dispositifs intra-utérins (DIU) ayant des frottis cervicaux de dépistage positifs pour actinomyces. Mises jour en gynécologie médicale 2008 Vigot [119-25]
46. C. Westhoff IUDs and colonization or infection with actinomyces Contraception 75 2007 S48 S50 (Pubitemid 46770706)
47. FFPRHC guidance. The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reprodctive helath. J Fam Plann Reprod Health Care 2004; 30:99-108.
48. O. Graesslin, and E. Derniaux Medical treatment of idiopathic menorrhagia J Gynecol Obstet Biol Reprod (Paris) 37 Suppl 8 2008 S384 S397
49. X. Lin, E.S. Gao, D. Li, M. Zhang, L.X. Dou, and W. Yuan Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women Acta Obstet Gynecol Scand 86 2007 1126 1129 (Pubitemid 47345792)
50. R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, and V. Fridman Endometrial vessel maturation in women exposed to levonorgestrel- releasing intrauterine system for a short or prolonged period of time Hum Reprod 22 2007 3084 3091 (Pubitemid 351696764)
51. A.J. Davies Reduction of menstrual blood loss by naproxen in intrauterine contraceptive device users Int J Gynaecol Obstet 17 1980 353 354
52. ESHRE Intrauterine devices and intrauterine systems Hum Reprod Update 14 2008 197 208
53. H. Marret, A. Fauconnier, N. Chabbert-Buffet, L. Cravello, F. Golfier, and J. Gondry Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause Eur J Obstet Gynecol Reprod Biol 152 2010 133 137
54. A. Gompel Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives J Gynecol Obstet Biol Reprod (Paris) 37 Suppl 8 2008 S356 S364
55. P. Lahteenmaki, M. Haukkamaa, J. Puolakka, U. Riikonen, S. Sainio, and J. Suvisaari Open randomised study of use of levonorgestrel-releasing intrauterine system as alternative to hysterectomy BMJ 316 1998 1122 1126 (Pubitemid 28156457)
56. I. Sivin IUDs and ectopic pregnancy Contraception 52 1995 321 322
57. T. Backman, I. Rauramo, S. Huhtala, and M. Koskenvuo Pregnancy during the use of levonorgestrel intrauterine system Am J Obstet Gynecol 190 2004 50 54 (Pubitemid 38156322)
58. G.T. Alvior Jr. Pregnancy outcome with removal of intrauterine device Obstet Gynecol 41 1973 894 896
59. H. Ganer, A. Levy, I. Ohel, and E. Sheiner Pregnancy outcome in women with an intrauterine contraceptive device Am J Obstet Gynecol 201 2009 e381 e385
60. D. Mansour Copper IUD and LNG IUS compared with tubal occlusion Contraception 75 2007 S144 S151 (Pubitemid 46773031)